Skip to main content
Top
Published in: Annals of Intensive Care 1/2015

Open Access 01-12-2015 | Review

Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors: Cédric Rafat, Martin Flamant, Stéphane Gaudry, Emmanuelle Vidal-Petiot, Jean-Damien Ricard, Didier Dreyfuss

Published in: Annals of Intensive Care | Issue 1/2015

Login to get access

Abstract

Hyponatremia is a common electrolyte derangement in the setting of the intensive care unit. Life-threatening neurological complications may arise not only in case of a severe (<120 mmol/L) and acute fall of plasma sodium levels, but may also stem from overly rapid correction of hyponatremia. Additionally, even mild hyponatremia carries a poor short-term and long-term prognosis across a wide range of conditions. Its multifaceted and intricate physiopathology may seem deterring at first glance, yet a careful multi-step diagnostic approach may easily unravel the underlying mechanisms and enable physicians to adopt the adequate measures at the patient’s bedside. Unless hyponatremia is associated with obvious extracellular fluid volume increase such as in heart failure or cirrhosis, hypertonic saline therapy is the cornerstone of the therapeutic of profound or severely symptomatic hyponatremia. When overcorrection of hyponatremia occurs, recent data indicate that re-lowering of plasma sodium levels through the infusion of hypotonic fluids and the cautious use of desmopressin acetate represent a reasonable strategy. New therapeutic options have recently emerged, foremost among these being vaptans, but their use in the setting of the intensive care unit remains to be clarified.
Literature
1.
go back to reference DeVita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol. 1990;34:163–6.PubMed DeVita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol. 1990;34:163–6.PubMed
2.
go back to reference Rosner MH, Ronco C. Dysnatremias in the intensive care unit. Contrib Nephrol. 2010;165:292–8.PubMed Rosner MH, Ronco C. Dysnatremias in the intensive care unit. Contrib Nephrol. 2010;165:292–8.PubMed
3.
go back to reference Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nat Rev Nephrol. 2013;9:37–50.PubMed Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nat Rev Nephrol. 2013;9:37–50.PubMed
4.
go back to reference Vandergheynst F, Sakr Y, Felleiter P, Hering R, Groeneveld J, Vanhems P, Taccone FS, Vincent JL. Incidence and prognosis of dysnatraemia in critically ill patients: analysis of a large prevalence study. Eur J Clin Investig. 2013;43:933–48. Vandergheynst F, Sakr Y, Felleiter P, Hering R, Groeneveld J, Vanhems P, Taccone FS, Vincent JL. Incidence and prognosis of dysnatraemia in critically ill patients: analysis of a large prevalence study. Eur J Clin Investig. 2013;43:933–48.
5.
go back to reference Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36:304–11.PubMed Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36:304–11.PubMed
6.
go back to reference Sakr Y, Rother S, Ferreira AM, Ewald C, Dunisch P, Riedemmann N, Reinhart K. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med. 2013;41:133–42.PubMed Sakr Y, Rother S, Ferreira AM, Ewald C, Dunisch P, Riedemmann N, Reinhart K. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med. 2013;41:133–42.PubMed
7.
go back to reference Sterns RH, Hix JK. Overcorrection of hyponatremia is a medical emergency. Kidney Int. 2009;76:587–9.PubMed Sterns RH, Hix JK. Overcorrection of hyponatremia is a medical emergency. Kidney Int. 2009;76:587–9.PubMed
8.
go back to reference McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med. 1995;333:1260–6.PubMed McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med. 1995;333:1260–6.PubMed
9.
go back to reference Strange K. Cellular volume homeostasis. Adv Physiol Educ. 2004;28:155–9.PubMed Strange K. Cellular volume homeostasis. Adv Physiol Educ. 2004;28:155–9.PubMed
10.
go back to reference Edelman IS, Leibman J, O’Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Investig. 1958;37:1236–56.PubMedCentralPubMed Edelman IS, Leibman J, O’Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Investig. 1958;37:1236–56.PubMedCentralPubMed
11.
go back to reference Cheuvront SN, Kenefick RW, Charkoudian N, Sawka MN. Physiologic basis for understanding quantitative dehydration assessment. Am J Clin Nutr. 2013;97:455–62.PubMed Cheuvront SN, Kenefick RW, Charkoudian N, Sawka MN. Physiologic basis for understanding quantitative dehydration assessment. Am J Clin Nutr. 2013;97:455–62.PubMed
12.
go back to reference Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci. 2008;9:519–31.PubMed Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci. 2008;9:519–31.PubMed
13.
go back to reference Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci. 2006;26:9069–75.PubMed Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci. 2006;26:9069–75.PubMed
14.
go back to reference Noda M, Sakuta H. Central regulation of body-fluid homeostasis. Trends Neurosci. 2013;36(11):661–73.PubMed Noda M, Sakuta H. Central regulation of body-fluid homeostasis. Trends Neurosci. 2013;36(11):661–73.PubMed
15.
go back to reference Sharif Naeini R, Witty MF, Seguela P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci. 2006;9:93–8. Sharif Naeini R, Witty MF, Seguela P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci. 2006;9:93–8.
16.
go back to reference Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4−/− mice. Proc Natl Acad Sci USA. 2003;100:13698–703.PubMedCentralPubMed Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4−/− mice. Proc Natl Acad Sci USA. 2003;100:13698–703.PubMedCentralPubMed
17.
go back to reference Choi-Kwon S, Baertschi AJ. Splanchnic osmosensation and vasopressin: mechanisms and neural pathways. Am J Physiol. 1991;261:E18–25.PubMed Choi-Kwon S, Baertschi AJ. Splanchnic osmosensation and vasopressin: mechanisms and neural pathways. Am J Physiol. 1991;261:E18–25.PubMed
18.
go back to reference Dooley CP, Valenzuela JE. Duodenal volume and osmoreceptors in the stimulation of human pancreatic secretion. Gastroenterology. 1984;86:23–7.PubMed Dooley CP, Valenzuela JE. Duodenal volume and osmoreceptors in the stimulation of human pancreatic secretion. Gastroenterology. 1984;86:23–7.PubMed
19.
go back to reference Honda K, Negoro H, Higuchi T, Tadokoro Y. The role of the anteroventral 3rd ventricle area in the osmotic control of paraventricular neurosecretory cells. Exp Brain Res. 1989;76:497–502.PubMed Honda K, Negoro H, Higuchi T, Tadokoro Y. The role of the anteroventral 3rd ventricle area in the osmotic control of paraventricular neurosecretory cells. Exp Brain Res. 1989;76:497–502.PubMed
20.
go back to reference Aradachi H, Honda K, Negoro H, Kubota T. Median preoptic neurones projecting to the supraoptic nucleus are sensitive to haemodynamic changes as well as to rise in plasma osmolality in rats. J Neuroendocrinol. 1996;8:35–43.PubMed Aradachi H, Honda K, Negoro H, Kubota T. Median preoptic neurones projecting to the supraoptic nucleus are sensitive to haemodynamic changes as well as to rise in plasma osmolality in rats. J Neuroendocrinol. 1996;8:35–43.PubMed
21.
go back to reference Hussy N, Deleuze C, Pantaloni A, Desarmenien MG, Moos F. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J Physiol. 1997;502(Pt 3):609–21.PubMedCentralPubMed Hussy N, Deleuze C, Pantaloni A, Desarmenien MG, Moos F. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J Physiol. 1997;502(Pt 3):609–21.PubMedCentralPubMed
22.
go back to reference Oliet SH, Bourque CW. Osmoreception in magnocellular neurosecretory cells: from single channels to secretion. Trends Neurosci. 1994;17:340–4.PubMed Oliet SH, Bourque CW. Osmoreception in magnocellular neurosecretory cells: from single channels to secretion. Trends Neurosci. 1994;17:340–4.PubMed
23.
go back to reference Halperin ML, Goldstein MB, Kamel KS. Fluid, electrolyte, and acid-base physiology a problem-based approach. In: Goldstein MB, editor. Book fluid, electrolyte, and acid-base physiology a problem-based approach. 4th ed. Philadelphia: Saunders/Elsevier; 2010. [pp. 1 online resource (xviii, 596 p.)]. Halperin ML, Goldstein MB, Kamel KS. Fluid, electrolyte, and acid-base physiology a problem-based approach. In: Goldstein MB, editor. Book fluid, electrolyte, and acid-base physiology a problem-based approach. 4th ed. Philadelphia: Saunders/Elsevier; 2010. [pp. 1 online resource (xviii, 596 p.)].
24.
go back to reference Stockand JD. Vasopressin regulation of renal sodium excretion. Kidney Int. 2010;78:849–56.PubMed Stockand JD. Vasopressin regulation of renal sodium excretion. Kidney Int. 2010;78:849–56.PubMed
25.
go back to reference Bankir L, Yang B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int. 2012;81:1179–98.PubMed Bankir L, Yang B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int. 2012;81:1179–98.PubMed
26.
go back to reference Kortenoeven ML, Pedersen NB, Rosenbaek LL, Fenton RA. Vasopressin regulation of sodium transport in the distal nephron and collecting duct. Am J Physiol Ren Physiol. 2015;309(4):F280–99. Kortenoeven ML, Pedersen NB, Rosenbaek LL, Fenton RA. Vasopressin regulation of sodium transport in the distal nephron and collecting duct. Am J Physiol Ren Physiol. 2015;309(4):F280–99.
27.
go back to reference Brenner BM, Rector FC. Brenner and Rector’s the kidney. 6th ed. Philadelphia: Saunders; 2000. Brenner BM, Rector FC. Brenner and Rector’s the kidney. 6th ed. Philadelphia: Saunders; 2000.
28.
go back to reference Gennari FJ. Current concepts. Serum osmolality. Uses and limitations. N Engl J Med. 1984;310:102–5.PubMed Gennari FJ. Current concepts. Serum osmolality. Uses and limitations. N Engl J Med. 1984;310:102–5.PubMed
29.
go back to reference Robertson GL. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 2001;30:671–694 (vii). Robertson GL. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 2001;30:671–694 (vii).
30.
go back to reference Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92:1813–64.PubMed Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92:1813–64.PubMed
31.
go back to reference Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, et al. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA. 2006;103:7807–12.PubMedCentralPubMed Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, et al. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA. 2006;103:7807–12.PubMedCentralPubMed
32.
go back to reference Gavras H, Hatzinikolaou P, North WG, Bresnahan M, Gavras I. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure. Hypertension. 1982;4:400–5.PubMed Gavras H, Hatzinikolaou P, North WG, Bresnahan M, Gavras I. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure. Hypertension. 1982;4:400–5.PubMed
33.
go back to reference Aoyagi T, Izumi Y, Hiroyama M, Matsuzaki T, Yasuoka Y, Sanbe A, Miyazaki H, Fujiwara Y, Nakayama Y, Kohda Y, et al. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Ren Physiol. 2008;295:F100–7. Aoyagi T, Izumi Y, Hiroyama M, Matsuzaki T, Yasuoka Y, Sanbe A, Miyazaki H, Fujiwara Y, Nakayama Y, Kohda Y, et al. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Ren Physiol. 2008;295:F100–7.
34.
go back to reference Arai S, Stotts N, Puntillo K. Thirst in critically ill patients: from physiology to sensation. Am J Crit Care. 2013;22:328–35.PubMedCentralPubMed Arai S, Stotts N, Puntillo K. Thirst in critically ill patients: from physiology to sensation. Am J Crit Care. 2013;22:328–35.PubMedCentralPubMed
35.
go back to reference Egan G, Silk T, Zamarripa F, Williams J, Federico P, Cunnington R, Carabott L, Blair-West J, Shade R, McKinley M, et al. Neural correlates of the emergence of consciousness of thirst. Proc Natl Acad Sci USA. 2003;100:15241–6.PubMedCentralPubMed Egan G, Silk T, Zamarripa F, Williams J, Federico P, Cunnington R, Carabott L, Blair-West J, Shade R, McKinley M, et al. Neural correlates of the emergence of consciousness of thirst. Proc Natl Acad Sci USA. 2003;100:15241–6.PubMedCentralPubMed
36.
go back to reference McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. News Physiol Sci. 2004;19:1–6.PubMed McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. News Physiol Sci. 2004;19:1–6.PubMed
37.
go back to reference Thunhorst RL, Johnson AK. Effects of hypotension and fluid depletion on central angiotensin-induced thirst and salt appetite. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1726–33.PubMed Thunhorst RL, Johnson AK. Effects of hypotension and fluid depletion on central angiotensin-induced thirst and salt appetite. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1726–33.PubMed
38.
go back to reference Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol. 2008;93:177–209.PubMed Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol. 2008;93:177–209.PubMed
39.
go back to reference Thunhorst RL, Lewis SJ, Johnson AK. Effects of sinoaortic baroreceptor denervation on depletion-induced salt appetite. Am J Physiol. 1994;267:R1043–9.PubMed Thunhorst RL, Lewis SJ, Johnson AK. Effects of sinoaortic baroreceptor denervation on depletion-induced salt appetite. Am J Physiol. 1994;267:R1043–9.PubMed
40.
go back to reference Thunhorst RL, Fitts DA. Peripheral angiotensin causes salt appetite in rats. Am J Physiol. 1994;267:R171–7.PubMed Thunhorst RL, Fitts DA. Peripheral angiotensin causes salt appetite in rats. Am J Physiol. 1994;267:R171–7.PubMed
41.
go back to reference Sakai RR, Nicolaidis S, Epstein AN. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol. 1986;251:R762–8.PubMed Sakai RR, Nicolaidis S, Epstein AN. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol. 1986;251:R762–8.PubMed
42.
go back to reference Johnson AK, Thunhorst RL. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol. 1997;18:292–353.PubMed Johnson AK, Thunhorst RL. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol. 1997;18:292–353.PubMed
43.
go back to reference Daniels D, Fluharty SJ. Salt appetite: a neurohormonal viewpoint. Physiol Behav. 2004;81:319–37.PubMed Daniels D, Fluharty SJ. Salt appetite: a neurohormonal viewpoint. Physiol Behav. 2004;81:319–37.PubMed
44.
go back to reference Navar LG. Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system. J Am Soc Hypertens. 2014;8:519–24.PubMedCentralPubMed Navar LG. Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system. J Am Soc Hypertens. 2014;8:519–24.PubMedCentralPubMed
45.
go back to reference Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 1990;113:155–9.PubMed Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 1990;113:155–9.PubMed
46.
go back to reference Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med. 2006;119:S47–53.PubMed Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med. 2006;119:S47–53.PubMed
47.
go back to reference Schrier RW. Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol. 2007;18:2028–31.PubMed Schrier RW. Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol. 2007;18:2028–31.PubMed
48.
go back to reference Schrier RW, Gottschalk CW. Diseases of the kidney. 6th ed. Boston: Little, Brown; 1997. Schrier RW, Gottschalk CW. Diseases of the kidney. 6th ed. Boston: Little, Brown; 1997.
49.
go back to reference Rasouli M, Kalantari KR. Comparison of methods for calculating serum osmolality: multivariate linear regression analysis. Clin Chem Lab Med. 2005;43:635–40.PubMed Rasouli M, Kalantari KR. Comparison of methods for calculating serum osmolality: multivariate linear regression analysis. Clin Chem Lab Med. 2005;43:635–40.PubMed
50.
go back to reference Sterns RH, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. Organic osmolytes in acute hyponatremia. Am J Physiol. 1993;264:F833–6.PubMed Sterns RH, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. Organic osmolytes in acute hyponatremia. Am J Physiol. 1993;264:F833–6.PubMed
51.
go back to reference Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol. 2009;29:257–70.PubMed Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol. 2009;29:257–70.PubMed
52.
go back to reference Leech P, Miller JD. Intracranial volume–pressure relationships during experimental brain compression in primates. 1. Pressure responses to changes in ventricular volume. J Neurol Neurosurg Psychiatry. 1974;37:1093–8.PubMedCentralPubMed Leech P, Miller JD. Intracranial volume–pressure relationships during experimental brain compression in primates. 1. Pressure responses to changes in ventricular volume. J Neurol Neurosurg Psychiatry. 1974;37:1093–8.PubMedCentralPubMed
53.
go back to reference Ayus JC, Arieff AI. Pathogenesis and prevention of hyponatremic encephalopathy. Endocrinol Metab Clin North Am. 1993;22:425–46.PubMed Ayus JC, Arieff AI. Pathogenesis and prevention of hyponatremic encephalopathy. Endocrinol Metab Clin North Am. 1993;22:425–46.PubMed
54.
go back to reference Sevick RJ, Kanda F, Mintorovitch J, Arieff AI, Kucharczyk J, Tsuruda JS, Norman D, Moseley ME. Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology. 1992;185:687–90.PubMed Sevick RJ, Kanda F, Mintorovitch J, Arieff AI, Kucharczyk J, Tsuruda JS, Norman D, Moseley ME. Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology. 1992;185:687–90.PubMed
55.
go back to reference Yalcin-Cakmakli G, Karli Oguz K, Shorbagi A, Funda Bas D, Ergan-Arsava B, Kunt M, Topcuoglu MA. Hyponatremic encephalopathy after excessive water ingestion prior to pelvic ultrasound: neuroimaging findings. Intern Med. 2010;49:1807–11. Yalcin-Cakmakli G, Karli Oguz K, Shorbagi A, Funda Bas D, Ergan-Arsava B, Kunt M, Topcuoglu MA. Hyponatremic encephalopathy after excessive water ingestion prior to pelvic ultrasound: neuroimaging findings. Intern Med. 2010;49:1807–11.
56.
go back to reference Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD. Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res. 2002;33:237–44.PubMed Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD. Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res. 2002;33:237–44.PubMed
57.
go back to reference Nase G, Helm PJ, Enger R, Ottersen OP. Water entry into astrocytes during brain edema formation. Glia. 2008;56:895–902.PubMed Nase G, Helm PJ, Enger R, Ottersen OP. Water entry into astrocytes during brain edema formation. Glia. 2008;56:895–902.PubMed
58.
go back to reference Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrol. 2007;22:778–84.PubMed Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrol. 2007;22:778–84.PubMed
59.
go back to reference Rash JE, Yasumura T, Hudson CS, Agre P, Nielsen S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA. 1998;95:11981–6.PubMedCentralPubMed Rash JE, Yasumura T, Hudson CS, Agre P, Nielsen S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA. 1998;95:11981–6.PubMedCentralPubMed
60.
go back to reference Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–63.PubMed Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–63.PubMed
61.
go back to reference Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119:S12–6.PubMed Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119:S12–6.PubMed
62.
go back to reference Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Ren Physiol. 2008;295:F619–24. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Ren Physiol. 2008;295:F619–24.
63.
go back to reference Olson JE, Sankar R, Holtzman D, James A, Fleischhacker D. Energy-dependent volume regulation in primary cultured cerebral astrocytes. J Cell Physiol. 1986;128:209–15.PubMed Olson JE, Sankar R, Holtzman D, James A, Fleischhacker D. Energy-dependent volume regulation in primary cultured cerebral astrocytes. J Cell Physiol. 1986;128:209–15.PubMed
64.
go back to reference Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Investig. 1991;88:303–9.PubMedCentralPubMed Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Investig. 1991;88:303–9.PubMedCentralPubMed
65.
go back to reference Massieu L, Montiel T, Robles G, Quesada O. Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies. Neurochem Res. 2004;29:73–81.PubMed Massieu L, Montiel T, Robles G, Quesada O. Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies. Neurochem Res. 2004;29:73–81.PubMed
66.
go back to reference Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res. 1991;567:274–82.PubMed Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res. 1991;567:274–82.PubMed
67.
go back to reference Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126:S1–42.PubMed Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126:S1–42.PubMed
68.
go back to reference Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med. 2014;40:320–31.PubMed Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med. 2014;40:320–31.PubMed
69.
go back to reference Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med. 1986;314:1529–35.PubMed Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med. 1986;314:1529–35.PubMed
70.
go back to reference Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29:282–99.PubMed Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29:282–99.PubMed
71.
go back to reference Fraser CL, Swanson RA. Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am J Physiol. 1994;267:C909–14.PubMed Fraser CL, Swanson RA. Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am J Physiol. 1994;267:C909–14.PubMed
72.
go back to reference Schwarz SM, Bostwick HE, Medow MS. Estrogen modulates ileal basolateral membrane lipid dynamics and Na+–K+-ATPase activity. Am J Physiol. 1988;254:G687–94.PubMed Schwarz SM, Bostwick HE, Medow MS. Estrogen modulates ileal basolateral membrane lipid dynamics and Na+–K+-ATPase activity. Am J Physiol. 1988;254:G687–94.PubMed
73.
go back to reference Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69:1319–25.PubMed Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69:1319–25.PubMed
74.
go back to reference Vexler ZS, Ayus JC, Roberts TP, Fraser CL, Kucharczyk J, Arieff AI. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J Clin Investig. 1994;93:256–64.PubMedCentralPubMed Vexler ZS, Ayus JC, Roberts TP, Fraser CL, Kucharczyk J, Arieff AI. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J Clin Investig. 1994;93:256–64.PubMedCentralPubMed
75.
go back to reference Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol. 1982;11:128–35.PubMed Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol. 1982;11:128–35.PubMed
76.
go back to reference Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–70.PubMed Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–70.PubMed
77.
go back to reference Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol. 1983;13:232–42.PubMed Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol. 1983;13:232–42.PubMed
78.
go back to reference Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–42.PubMed Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–42.PubMed
79.
go back to reference Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;4:1522–30.PubMed Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;4:1522–30.PubMed
80.
go back to reference Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol. 1984;15:544–7.PubMed Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol. 1984;15:544–7.PubMed
81.
go back to reference Malhotra K, Ortega L. Central pontine myelinolysis with meticulous correction of hyponatraemia in chronic alcoholics. BMJ Case Rep 2013. 2013. doi:10.1136/bcr-2013-009970. Malhotra K, Ortega L. Central pontine myelinolysis with meticulous correction of hyponatraemia in chronic alcoholics. BMJ Case Rep 2013. 2013. doi:10.​1136/​bcr-2013-009970.
82.
go back to reference Georgy V, Mullhi D, Jones AF. Central pontine myelinolysis following ‘optimal’ rate of correction of hyponatraemia with a good clinical outcome. Ann Clin Biochem. 2007;44:488–90.PubMed Georgy V, Mullhi D, Jones AF. Central pontine myelinolysis following ‘optimal’ rate of correction of hyponatraemia with a good clinical outcome. Ann Clin Biochem. 2007;44:488–90.PubMed
83.
go back to reference Dellabarca C, Servilla KS, Hart B, Murata GH, Tzamaloukas AH. Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. Int Urol Nephrol. 2005;37:171–3.PubMed Dellabarca C, Servilla KS, Hart B, Murata GH, Tzamaloukas AH. Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. Int Urol Nephrol. 2005;37:171–3.PubMed
84.
go back to reference Bhat S, Koulaouzidis A, Haris M, Tan C. Central pontine myelinolysis. Ann Hepatol. 2006;5:291–2.PubMed Bhat S, Koulaouzidis A, Haris M, Tan C. Central pontine myelinolysis. Ann Hepatol. 2006;5:291–2.PubMed
85.
go back to reference Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol. 2001;55:248–53.PubMed Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol. 2001;55:248–53.PubMed
86.
go back to reference de Souza A. Akinetic-rigid syndrome due to extrapontine and pontine myelinolysis following appropriate correction of hyponatraemia. J Clin Neurosci. 2011;18:587–9.PubMed de Souza A. Akinetic-rigid syndrome due to extrapontine and pontine myelinolysis following appropriate correction of hyponatraemia. J Clin Neurosci. 2011;18:587–9.PubMed
87.
go back to reference Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci. 1996;142:134–9.PubMed Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci. 1996;142:134–9.PubMed
88.
go back to reference Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol. 2001;8:103–9.PubMed Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol. 2001;8:103–9.PubMed
89.
go back to reference Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72.PubMed Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72.PubMed
90.
go back to reference Norenberg MD. Central pontine myelinolysis: historical and mechanistic considerations. Metab Brain Dis. 2010;25:97–106.PubMed Norenberg MD. Central pontine myelinolysis: historical and mechanistic considerations. Metab Brain Dis. 2010;25:97–106.PubMed
91.
go back to reference Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol. 1987;6:262–70.PubMed Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol. 1987;6:262–70.PubMed
92.
go back to reference Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 3:iii22–28. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 3:iii22–28.
93.
go back to reference Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int. 1991;39:1274–82.PubMed Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int. 1991;39:1274–82.PubMed
94.
go back to reference Rojiani AM, Prineas JW, Cho ES. Electrolyte-induced demyelination in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol. 1994;88:287–92.PubMed Rojiani AM, Prineas JW, Cho ES. Electrolyte-induced demyelination in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol. 1994;88:287–92.PubMed
95.
go back to reference Rojiani AM, Prineas JW, Cho ES. Protective effect of steroids in electrolyte-induced demyelination. J Neuropathol Exp Neurol. 1987;46:495–504.PubMed Rojiani AM, Prineas JW, Cho ES. Protective effect of steroids in electrolyte-induced demyelination. J Neuropathol Exp Neurol. 1987;46:495–504.PubMed
96.
go back to reference Takefuji S, Murase T, Sugimura Y, Takagishi Y, Hayasaka S, Oiso Y, Murata Y. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol. 2007;204:88–94.PubMed Takefuji S, Murase T, Sugimura Y, Takagishi Y, Hayasaka S, Oiso Y, Murata Y. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol. 2007;204:88–94.PubMed
97.
go back to reference Iwama S, Sugimura Y, Suzuki H, Murase T, Ozaki N, Nagasaki H, Arima H, Murata Y, Sawada M, Oiso Y. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome. Glia. 2011;59:452–62.PubMed Iwama S, Sugimura Y, Suzuki H, Murase T, Ozaki N, Nagasaki H, Arima H, Murata Y, Sawada M, Oiso Y. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome. Glia. 2011;59:452–62.PubMed
98.
go back to reference Gankam-Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Minocycline protects against neurologic complications of rapid correction of hyponatremia. J Am Soc Nephrol. 2010;21:2099–108.PubMedCentralPubMed Gankam-Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Minocycline protects against neurologic complications of rapid correction of hyponatremia. J Am Soc Nephrol. 2010;21:2099–108.PubMedCentralPubMed
99.
go back to reference Suzuki H, Sugimura Y, Iwama S, Nobuaki O, Nagasaki H, Arima H, Sawada M, Oiso Y. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol. 2010;21:2090–8.PubMedCentralPubMed Suzuki H, Sugimura Y, Iwama S, Nobuaki O, Nagasaki H, Arima H, Sawada M, Oiso Y. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol. 2010;21:2090–8.PubMedCentralPubMed
100.
go back to reference Laitt RD, Thornton M, Goddard P. Pontine myelinolysis in a normonatraemic alcoholic. Clin Radiol. 1993;48:432–3.PubMed Laitt RD, Thornton M, Goddard P. Pontine myelinolysis in a normonatraemic alcoholic. Clin Radiol. 1993;48:432–3.PubMed
101.
go back to reference Mascalchi M, Cincotta M, Piazzini M. Case report: MRI demonstration of pontine and thalamic myelinolysis in a normonatraemic alcoholic. Clin Radiol. 1993;47:137–8.PubMed Mascalchi M, Cincotta M, Piazzini M. Case report: MRI demonstration of pontine and thalamic myelinolysis in a normonatraemic alcoholic. Clin Radiol. 1993;47:137–8.PubMed
102.
go back to reference Mochizuki H, Masaki T, Miyakawa T, Nakane J, Yokoyama A, Nakamura Y, Okuyama K, Kamakura K, Motoyoshi K, Matsushita S, Higuchi S. Benign type of central pontine myelinolysis in alcoholism–clinical, neuroradiological and electrophysiological findings. J Neurol. 2003;250:1077–83.PubMed Mochizuki H, Masaki T, Miyakawa T, Nakane J, Yokoyama A, Nakamura Y, Okuyama K, Kamakura K, Motoyoshi K, Matsushita S, Higuchi S. Benign type of central pontine myelinolysis in alcoholism–clinical, neuroradiological and electrophysiological findings. J Neurol. 2003;250:1077–83.PubMed
103.
go back to reference Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, Andruetto P, Panio A, Ballaris MA, Lavezzo B, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006;38:789–92.PubMed Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, Andruetto P, Panio A, Ballaris MA, Lavezzo B, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006;38:789–92.PubMed
104.
go back to reference Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004;10:2540–3.PubMedCentralPubMed Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004;10:2540–3.PubMedCentralPubMed
105.
go back to reference Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol. 2002;47:3–10.PubMed Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol. 2002;47:3–10.PubMed
106.
go back to reference Vizzini G, Asaro M, Miraglia R, Gruttadauria S, Fili D, D’Antoni A, Petridis I, Marrone G, Pagano D, Gridelli B. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl. 2011;17:1279–85.PubMed Vizzini G, Asaro M, Miraglia R, Gruttadauria S, Fili D, D’Antoni A, Petridis I, Marrone G, Pagano D, Gridelli B. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl. 2011;17:1279–85.PubMed
107.
go back to reference Heng AE, Vacher P, Aublet-Cuvelier B, Garcier JM, Sapin V, Deteix P, Souweine B. Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol. 2007;67:345–51.PubMed Heng AE, Vacher P, Aublet-Cuvelier B, Garcier JM, Sapin V, Deteix P, Souweine B. Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol. 2007;67:345–51.PubMed
108.
go back to reference Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis. 2010;55:742–8.PubMed Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis. 2010;55:742–8.PubMed
109.
go back to reference Soupart A, Silver S, Schrooeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol. 2002;13:1433–41.PubMed Soupart A, Silver S, Schrooeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol. 2002;13:1433–41.PubMed
110.
go back to reference Huang WY, Weng WC, Peng TI, Ro LS, Yang CW, Chen KH. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail. 2007;29:635–8.PubMed Huang WY, Weng WC, Peng TI, Ro LS, Yang CW, Chen KH. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail. 2007;29:635–8.PubMed
111.
go back to reference Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol. 2004;182:809–16.PubMed Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol. 2004;182:809–16.PubMed
112.
go back to reference Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121–9. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121–9.
113.
go back to reference Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581–9.PubMed Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581–9.PubMed
114.
go back to reference Decaux G. Is asymptomatic hyponatremia really asymptomatic? Am J Med. 2006;119:S79–82.PubMed Decaux G. Is asymptomatic hyponatremia really asymptomatic? Am J Med. 2006;119:S79–82.PubMed
115.
go back to reference Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia. 2011;52:410–3.PubMed Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia. 2011;52:410–3.PubMed
116.
go back to reference Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042–4.PubMed Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042–4.PubMed
117.
go back to reference Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107:517–21.PubMed Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107:517–21.PubMed
118.
go back to reference Laubenberger J, Schneider B, Ansorge O, Gotz F, Haussinger D, Volk B, Langer M. Central pontine myelinolysis: clinical presentation and radiologic findings. Eur Radiol. 1996;6:177–83.PubMed Laubenberger J, Schneider B, Ansorge O, Gotz F, Haussinger D, Volk B, Langer M. Central pontine myelinolysis: clinical presentation and radiologic findings. Eur Radiol. 1996;6:177–83.PubMed
119.
go back to reference de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord. 2013;19:709–16.PubMed de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord. 2013;19:709–16.PubMed
120.
121.
go back to reference Odier C, Nguyen DK, Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol. 2010;257:1176–80.PubMed Odier C, Nguyen DK, Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol. 2010;257:1176–80.PubMed
122.
go back to reference Forster A, Nolte I, Wenz H, Al-Zghloul M, Kerl HU, Brockmann C, Brockmann MA, Groden C. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology. 2013;55:49–56.PubMed Forster A, Nolte I, Wenz H, Al-Zghloul M, Kerl HU, Brockmann C, Brockmann MA, Groden C. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology. 2013;55:49–56.PubMed
123.
go back to reference Kumar S, Fowler M, Gonzalez-Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurol Res. 2006;28:360–6.PubMed Kumar S, Fowler M, Gonzalez-Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurol Res. 2006;28:360–6.PubMed
124.
go back to reference Louis G, Megarbane B, Lavoue S, Lassalle V, Argaud L, Poussel JF, Georges H, Bollaert PE. Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*. Crit Care Med. 2012;40:970–2.PubMed Louis G, Megarbane B, Lavoue S, Lassalle V, Argaud L, Poussel JF, Georges H, Bollaert PE. Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*. Crit Care Med. 2012;40:970–2.PubMed
125.
go back to reference Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry. 2011;82:326–31.PubMed Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry. 2011;82:326–31.PubMed
126.
go back to reference Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec’h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, et al. Prognostic consequences of borderline dysnatraemia: pay attention to minimal serum sodium change. Crit Care. 2013;17:R12.PubMedCentralPubMed Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec’h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, et al. Prognostic consequences of borderline dysnatraemia: pay attention to minimal serum sodium change. Crit Care. 2013;17:R12.PubMedCentralPubMed
127.
go back to reference Bennani SL, Abouqal R, Zeggwagh AA, Madani N, Abidi K, Zekraoui A, Kerkeb O. Incidence, causes and prognostic factors of hyponatremia in intensive care. Rev Med Intern. 2003;24:224–9. Bennani SL, Abouqal R, Zeggwagh AA, Madani N, Abidi K, Zekraoui A, Kerkeb O. Incidence, causes and prognostic factors of hyponatremia in intensive care. Rev Med Intern. 2003;24:224–9.
128.
go back to reference Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care. 2008;12:R162.PubMedCentralPubMed Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care. 2008;12:R162.PubMedCentralPubMed
129.
go back to reference Zilberberg MD, Exuzides A, Spalding J, Foreman A, Jones AG, Colby C, Shorr AF. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24:1601–8.PubMed Zilberberg MD, Exuzides A, Spalding J, Foreman A, Jones AG, Colby C, Shorr AF. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24:1601–8.PubMed
130.
go back to reference Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170:294–302.PubMed Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170:294–302.PubMed
131.
go back to reference Dreyfuss D, Leviel F, Paillard M, Rahmani J, Coste F. Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion. Am Rev Respir Dis. 1988;138:583–9.PubMed Dreyfuss D, Leviel F, Paillard M, Rahmani J, Coste F. Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion. Am Rev Respir Dis. 1988;138:583–9.PubMed
132.
go back to reference Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-acquired pneumonia. Am J Nephrol. 2007;27:184–90.PubMed Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-acquired pneumonia. Am J Nephrol. 2007;27:184–90.PubMed
133.
go back to reference Krumholz HM, Chen YT, Bradford WD, Cerese J. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care. 1999;5:715–23.PubMed Krumholz HM, Chen YT, Bradford WD, Cerese J. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care. 1999;5:715–23.PubMed
134.
go back to reference Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73:257–67.PubMed Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73:257–67.PubMed
135.
go back to reference Milo-Cotter O, Cotter G, Weatherley BD, Adams KF, Kaluski E, Uriel N, O’Connor CM, Felker GM. Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia. Eur J Heart Fail. 2008;10:196–200.PubMed Milo-Cotter O, Cotter G, Weatherley BD, Adams KF, Kaluski E, Uriel N, O’Connor CM, Felker GM. Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia. Eur J Heart Fail. 2008;10:196–200.PubMed
136.
go back to reference Restuccia T, Gomez-Anson B, Guevara M, Alessandria C, Torre A, Alayrach ME, Terra C, Martin M, Castellvi M, Rami L, et al. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology. 2004;39:1613–22.PubMed Restuccia T, Gomez-Anson B, Guevara M, Alessandria C, Torre A, Alayrach ME, Terra C, Martin M, Castellvi M, Rami L, et al. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology. 2004;39:1613–22.PubMed
137.
go back to reference Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002–10.PubMed Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002–10.PubMed
138.
go back to reference Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677–84.PubMedCentralPubMed Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677–84.PubMedCentralPubMed
139.
go back to reference Rodrigues B, Staff I, Fortunato G, McCullough LD. Hyponatremia in the prognosis of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;23(5):850–4.PubMed Rodrigues B, Staff I, Fortunato G, McCullough LD. Hyponatremia in the prognosis of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;23(5):850–4.PubMed
140.
go back to reference Roca B, Tornador N, Tornador E. Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study. Epidemiol Infect. 2008;136:1455–62.PubMedCentralPubMed Roca B, Tornador N, Tornador E. Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study. Epidemiol Infect. 2008;136:1455–62.PubMedCentralPubMed
141.
go back to reference Chao YN, Chiu NC, Huang FY. Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect. 2008;41:48–53.PubMed Chao YN, Chiu NC, Huang FY. Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect. 2008;41:48–53.PubMed
142.
go back to reference Igarashi T, Moro N, Katayama Y, Mori T, Kojima J, Kawamata T. Prediction of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: relationship to cerebral salt wasting syndrome. Neurol Res. 2007;29:835–41.PubMed Igarashi T, Moro N, Katayama Y, Mori T, Kojima J, Kawamata T. Prediction of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: relationship to cerebral salt wasting syndrome. Neurol Res. 2007;29:835–41.PubMed
143.
go back to reference Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:1820–32.PubMed Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:1820–32.PubMed
144.
go back to reference Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471–503.PubMed Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471–503.PubMed
145.
go back to reference Fenske W, Maier SK, Blechschmidt A, Allolio B, Stork S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am J Med. 2010;123:652–7.PubMed Fenske W, Maier SK, Blechschmidt A, Allolio B, Stork S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am J Med. 2010;123:652–7.PubMed
146.
go back to reference Fortgens P, Pillay TS. Pseudohyponatremia revisited: a modern-day pitfall. Arch Pathol Lab Med. 2011;135:516–9.PubMed Fortgens P, Pillay TS. Pseudohyponatremia revisited: a modern-day pitfall. Arch Pathol Lab Med. 2011;135:516–9.PubMed
147.
go back to reference Goldwasser P, Ayoub I, Barth RH. Pseudohypernatremia and pseudohyponatremia: a linear correction. Nephrol Dial Transplant. 2014;30(2):252–7.PubMed Goldwasser P, Ayoub I, Barth RH. Pseudohypernatremia and pseudohyponatremia: a linear correction. Nephrol Dial Transplant. 2014;30(2):252–7.PubMed
148.
go back to reference Seldin DW, Tarail R. The metabolism of glucose and electrolytes in diabetic acidosis. J Clin Investig. 1950;29:552–65.PubMedCentralPubMed Seldin DW, Tarail R. The metabolism of glucose and electrolytes in diabetic acidosis. J Clin Investig. 1950;29:552–65.PubMedCentralPubMed
149.
go back to reference Bohn D, Daneman D. Diabetic ketoacidosis and cerebral edema. Curr Opin Pediatr. 2002;14:287–91.PubMed Bohn D, Daneman D. Diabetic ketoacidosis and cerebral edema. Curr Opin Pediatr. 2002;14:287–91.PubMed
150.
go back to reference Katz MA. Hyperglycemia-induced hyponatremia–calculation of expected serum sodium depression. N Engl J Med. 1973;289:843–4.PubMed Katz MA. Hyperglycemia-induced hyponatremia–calculation of expected serum sodium depression. N Engl J Med. 1973;289:843–4.PubMed
151.
go back to reference Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106:399–403.PubMed Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106:399–403.PubMed
152.
go back to reference Creevy CD. Hemolytic reactions during transurethral prostatic resection. J Urol. 1947;58:125–31.PubMed Creevy CD. Hemolytic reactions during transurethral prostatic resection. J Urol. 1947;58:125–31.PubMed
153.
go back to reference Rothenberg DM, Berns AS, Ivankovich AD. Isotonic hyponatremia following transurethral prostate resection. J Clin Anesth. 1990;2:48–53.PubMed Rothenberg DM, Berns AS, Ivankovich AD. Isotonic hyponatremia following transurethral prostate resection. J Clin Anesth. 1990;2:48–53.PubMed
154.
go back to reference Ayus JC, Arieff AI. Glycine-induced hypo-osmolar hyponatremia. Arch Intern Med. 1997;157:223–6.PubMed Ayus JC, Arieff AI. Glycine-induced hypo-osmolar hyponatremia. Arch Intern Med. 1997;157:223–6.PubMed
155.
go back to reference Allgen LG, Norlen H, Kolmert T, Berg K. Absorption and elimination of mannitol solution when used as an isotonic irrigating agent in connection with transurethral resection of the prostate. Scand J Urol Nephrol. 1987;21:177–84.PubMed Allgen LG, Norlen H, Kolmert T, Berg K. Absorption and elimination of mannitol solution when used as an isotonic irrigating agent in connection with transurethral resection of the prostate. Scand J Urol Nephrol. 1987;21:177–84.PubMed
156.
go back to reference Hahn RG. Fluid absorption in endoscopic surgery. Br J Anaesth. 2006;96:8–20.PubMed Hahn RG. Fluid absorption in endoscopic surgery. Br J Anaesth. 2006;96:8–20.PubMed
157.
go back to reference Hoekstra PT, Kahnoski R, McCamish MA, Bergen W, Heetderks DR. Transurethral prostatic resection syndrome–a new perspective: encephalopathy with associated hyperammonemia. J Urol. 1983;130:704–7.PubMed Hoekstra PT, Kahnoski R, McCamish MA, Bergen W, Heetderks DR. Transurethral prostatic resection syndrome–a new perspective: encephalopathy with associated hyperammonemia. J Urol. 1983;130:704–7.PubMed
158.
go back to reference Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry. 2008;16:13–24.PubMed Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry. 2008;16:13–24.PubMed
159.
go back to reference Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis. 2007;50:673–80.PubMed Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis. 2007;50:673–80.PubMed
160.
go back to reference Hoorn EJ, Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron Physiol. 2008;108:p46–59.PubMed Hoorn EJ, Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron Physiol. 2008;108:p46–59.PubMed
161.
go back to reference Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42:790–806.PubMed Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42:790–806.PubMed
162.
go back to reference Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905–8.PubMed Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905–8.PubMed
163.
go back to reference McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA. 1999;281:1022–9.PubMed McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA. 1999;281:1022–9.PubMed
164.
go back to reference Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064–72.PubMed Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064–72.PubMed
165.
go back to reference Decaux G, Prospert F, Cauchie P, Soupart A. Dissociation between uric acid and urea clearances in the syndrome of inappropriate secretion of antidiuretic hormone related to salt excretion. Clin Sci (Lond). 1990;78:451–5. Decaux G, Prospert F, Cauchie P, Soupart A. Dissociation between uric acid and urea clearances in the syndrome of inappropriate secretion of antidiuretic hormone related to salt excretion. Clin Sci (Lond). 1990;78:451–5.
166.
go back to reference Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008;3:1175–84.PubMed Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008;3:1175–84.PubMed
167.
go back to reference Decaux G, Schlesser M, Coffernils M, Prospert F, Namias B, Brimioulle S, Soupart A. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol. 1994;42:102–8.PubMed Decaux G, Schlesser M, Coffernils M, Prospert F, Namias B, Brimioulle S, Soupart A. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol. 1994;42:102–8.PubMed
169.
go back to reference Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med. 2006;119:S21–9.PubMed Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med. 2006;119:S21–9.PubMed
170.
go back to reference Manoogian C, Pandian M, Ehrlich L, Fisher D, Horton R. Plasma atrial natriuretic hormone levels in patients with the syndrome of inappropriate antidiuretic hormone secretion. J Clin Endocrinol Metab. 1988;67:571–5.PubMed Manoogian C, Pandian M, Ehrlich L, Fisher D, Horton R. Plasma atrial natriuretic hormone levels in patients with the syndrome of inappropriate antidiuretic hormone secretion. J Clin Endocrinol Metab. 1988;67:571–5.PubMed
171.
go back to reference Saito T, Higashiyama M, Nagasaka S, Sasaki S, Ishikawa SE. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int. 2001;60:1266–76.PubMed Saito T, Higashiyama M, Nagasaka S, Sasaki S, Ishikawa SE. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int. 2001;60:1266–76.PubMed
172.
go back to reference Ecelbarger CA, Nielsen S, Olson BR, Murase T, Baker EA, Knepper MA, Verbalis JG. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Investig. 1997;99:1852–63.PubMedCentralPubMed Ecelbarger CA, Nielsen S, Olson BR, Murase T, Baker EA, Knepper MA, Verbalis JG. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Investig. 1997;99:1852–63.PubMedCentralPubMed
173.
go back to reference Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23:529–42.PubMed Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23:529–42.PubMed
174.
go back to reference Decaux G. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Semin Nephrol. 2009;29:239–56.PubMed Decaux G. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Semin Nephrol. 2009;29:239–56.PubMed
175.
go back to reference Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006;35:687–98 (vii–viii). Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006;35:687–98 (vii–viii).
176.
go back to reference Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet. 1997;350:755–6.PubMed Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet. 1997;350:755–6.PubMed
177.
go back to reference Sun GE, Pantalone KM, Hatipoglu B. Hypothyroidism as a cause of hyponatremia: fact or fiction? Endocr Pract. 2012;18:894–7.PubMed Sun GE, Pantalone KM, Hatipoglu B. Hypothyroidism as a cause of hyponatremia: fact or fiction? Endocr Pract. 2012;18:894–7.PubMed
178.
go back to reference Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol. 2003;149:177–8.PubMed Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol. 2003;149:177–8.PubMed
179.
go back to reference Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148:609–17.PubMed Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148:609–17.PubMed
180.
go back to reference Ishikawa S, Schrier RW. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int. 1982;22:587–93.PubMed Ishikawa S, Schrier RW. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int. 1982;22:587–93.PubMed
181.
go back to reference Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA. 1984;81:1883–7.PubMedCentralPubMed Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA. 1984;81:1883–7.PubMedCentralPubMed
182.
go back to reference Rowe JW, Shelton RL, Helderman JH, Vestal RE, Robertson GL. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979;16:729–35.PubMed Rowe JW, Shelton RL, Helderman JH, Vestal RE, Robertson GL. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979;16:729–35.PubMed
183.
go back to reference Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol. 1979;236:F321–32.PubMed Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol. 1979;236:F321–32.PubMed
184.
go back to reference Dreyfuss D, Leviel F, Sperandio M, Paillard M, Marty J, Coste F. Does the stress of admission to an intensive care unit influence arginine vasopressin secretion and renal diluting ability? Intensive Care Med. 1990;16:323–7.PubMed Dreyfuss D, Leviel F, Sperandio M, Paillard M, Marty J, Coste F. Does the stress of admission to an intensive care unit influence arginine vasopressin secretion and renal diluting ability? Intensive Care Med. 1990;16:323–7.PubMed
185.
go back to reference Swart RM, Hoorn EJ, Betjes MG, Zietse R. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118:45–51.PubMed Swart RM, Hoorn EJ, Betjes MG, Zietse R. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118:45–51.PubMed
186.
go back to reference Ferreira da Cunha D, Pontes Monteiro J, Modesto dos Santos V, Araujo Oliveira F, Freire de Carvalho da Cunha S. Hyponatremia in acute-phase response syndrome patients in general surgical wards. Am J Nephrol. 2000;20:37–41. Ferreira da Cunha D, Pontes Monteiro J, Modesto dos Santos V, Araujo Oliveira F, Freire de Carvalho da Cunha S. Hyponatremia in acute-phase response syndrome patients in general surgical wards. Am J Nephrol. 2000;20:37–41.
187.
go back to reference Benrick A, Schele E, Pinnock SB, Wernstedt-Asterholm I, Dickson SL, Karlsson-Lindahl L, Jansson JO. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei. J Neuroendocrinol. 2009;21:620–8.PubMed Benrick A, Schele E, Pinnock SB, Wernstedt-Asterholm I, Dickson SL, Karlsson-Lindahl L, Jansson JO. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei. J Neuroendocrinol. 2009;21:620–8.PubMed
188.
go back to reference Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, Murphy D. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem. 2003;278:19280–5.PubMed Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, Murphy D. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem. 2003;278:19280–5.PubMed
189.
go back to reference Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994;79:934–9.PubMed Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994;79:934–9.PubMed
190.
go back to reference Goldstein CS, Braunstein S, Goldfarb S. Idiopathic syndrome of inappropriate antidiuretic hormone secretion possibly related to advanced age. Ann Intern Med. 1983;99:185–8.PubMed Goldstein CS, Braunstein S, Goldfarb S. Idiopathic syndrome of inappropriate antidiuretic hormone secretion possibly related to advanced age. Ann Intern Med. 1983;99:185–8.PubMed
191.
go back to reference Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr Soc. 2001;49:788–92.PubMed Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr Soc. 2001;49:788–92.PubMed
192.
go back to reference Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352:1550–6.PubMed Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352:1550–6.PubMed
193.
go back to reference Rosner MH, Kirven J. Exercise-associated hyponatremia. Clin J Am Soc Nephrol. 2007;2:151–61.PubMed Rosner MH, Kirven J. Exercise-associated hyponatremia. Clin J Am Soc Nephrol. 2007;2:151–61.PubMed
194.
go back to reference Siegel AJ, Verbalis JG, Clement S, Mendelson JH, Mello NK, Adner M, Shirey T, Glowacki J, Lee-Lewandrowski E, Lewandrowski KB. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120(461):e411–67. Siegel AJ, Verbalis JG, Clement S, Mendelson JH, Mello NK, Adner M, Shirey T, Glowacki J, Lee-Lewandrowski E, Lewandrowski KB. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120(461):e411–67.
195.
go back to reference Noakes TD, Sharwood K, Speedy D, Hew T, Reid S, Dugas J, Almond C, Wharam P, Weschler L. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci USA. 2005;102:18550–5.PubMedCentralPubMed Noakes TD, Sharwood K, Speedy D, Hew T, Reid S, Dugas J, Almond C, Wharam P, Weschler L. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci USA. 2005;102:18550–5.PubMedCentralPubMed
196.
go back to reference Siegel AJ. Exercise-associated hyponatremia: role of cytokines. Am J Med. 2006;119:S74–8.PubMed Siegel AJ. Exercise-associated hyponatremia: role of cytokines. Am J Med. 2006;119:S74–8.PubMed
197.
go back to reference Thompson C, Berl T, Tejedor A, Johannsson G. Differential diagnosis of hyponatraemia. Best Pract Res Clin Endocrinol Metab. 2012;26(Suppl 1):S7–15.PubMed Thompson C, Berl T, Tejedor A, Johannsson G. Differential diagnosis of hyponatraemia. Best Pract Res Clin Endocrinol Metab. 2012;26(Suppl 1):S7–15.PubMed
198.
go back to reference Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (second of two parts). N Engl J Med. 1975;292:141–5.PubMed Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (second of two parts). N Engl J Med. 1975;292:141–5.PubMed
199.
go back to reference Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981;305:263–6.PubMed Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981;305:263–6.PubMed
200.
go back to reference Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (first of two parts). N Engl J Med. 1975;292:81–8.PubMed Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (first of two parts). N Engl J Med. 1975;292:81–8.PubMed
201.
go back to reference Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.PubMed Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.PubMed
202.
go back to reference Usberti M, Federico S, Meccariello S, Cianciaruso B, Balletta M, Pecoraro C, Sacca L, Ungaro B, Pisanti N, Andreucci VE. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422–9.PubMed Usberti M, Federico S, Meccariello S, Cianciaruso B, Balletta M, Pecoraro C, Sacca L, Ungaro B, Pisanti N, Andreucci VE. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422–9.PubMed
203.
go back to reference Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82:635–42.PubMed Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82:635–42.PubMed
204.
go back to reference ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97.
205.
go back to reference Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006;61:87–95.PubMedCentralPubMed Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006;61:87–95.PubMedCentralPubMed
206.
go back to reference Hix JK, Silver S, Sterns RH. Diuretic-associated hyponatremia. Semin Nephrol. 2011;31:553–66.PubMed Hix JK, Silver S, Sterns RH. Diuretic-associated hyponatremia. Semin Nephrol. 2011;31:553–66.PubMed
207.
go back to reference Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19:447–52.PubMed Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19:447–52.PubMed
208.
go back to reference Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103:601–6.PubMed Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103:601–6.PubMed
209.
go back to reference Kromah F, Tyroch A, McLean S, Hughes H, Flavin N, Lee S. Relative adrenal insufficiency in the critical care setting: debunking the classic myth. World J Surg. 2011;35:1818–23.PubMed Kromah F, Tyroch A, McLean S, Hughes H, Flavin N, Lee S. Relative adrenal insufficiency in the critical care setting: debunking the classic myth. World J Surg. 2011;35:1818–23.PubMed
210.
go back to reference Nerup J. Addison’s disease—clinical studies. A report fo 108 cases. Acta Endocrinol (Cph). 1974;76:127–41. Nerup J. Addison’s disease—clinical studies. A report fo 108 cases. Acta Endocrinol (Cph). 1974;76:127–41.
211.
go back to reference Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011;96:E925–8.PubMed Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011;96:E925–8.PubMed
212.
go back to reference Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: What difference? J Am Soc Nephrol. 2008;19:194–6.PubMed Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: What difference? J Am Soc Nephrol. 2008;19:194–6.PubMed
213.
go back to reference Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting? Kidney Int. 2009;76:934–8.PubMed Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting? Kidney Int. 2009;76:934–8.PubMed
214.
go back to reference Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21:339–52.PubMed Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21:339–52.PubMed
215.
go back to reference Bitew S, Imbriano L, Miyawaki N, Fishbane S, Maesaka JK. More on renal salt wasting without cerebral disease: response to saline infusion. Clin J Am Soc Nephrol. 2009;4:309–15.PubMedCentralPubMed Bitew S, Imbriano L, Miyawaki N, Fishbane S, Maesaka JK. More on renal salt wasting without cerebral disease: response to saline infusion. Clin J Am Soc Nephrol. 2009;4:309–15.PubMedCentralPubMed
216.
go back to reference Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18:211–6.PubMed Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18:211–6.PubMed
217.
go back to reference Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg. 1981;55:938–41.PubMed Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg. 1981;55:938–41.PubMed
218.
go back to reference Peters JP, Welt LG, Sims EA, Orloff J, Needham J. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians. 1950;63:57–64.PubMed Peters JP, Welt LG, Sims EA, Orloff J, Needham J. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians. 1950;63:57–64.PubMed
219.
go back to reference Palmer BF. Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant. 2000;15:262–8.PubMed Palmer BF. Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant. 2000;15:262–8.PubMed
220.
go back to reference Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998;29:1584–7.PubMed Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998;29:1584–7.PubMed
221.
go back to reference Becker A, Baum M. Obstructive uropathy. Early Hum Dev. 2006;82:15–22.PubMed Becker A, Baum M. Obstructive uropathy. Early Hum Dev. 2006;82:15–22.PubMed
222.
go back to reference Iyer AV, Krasnow SH, Dufour DR, Arcenas AS. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer. Clin Lung Cancer. 2003;5:187–9.PubMed Iyer AV, Krasnow SH, Dufour DR, Arcenas AS. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer. Clin Lung Cancer. 2003;5:187–9.PubMed
223.
go back to reference Cogan MC, Arieff AI. Sodium wasting, acidosis and hyperkalemia induced by methicillin interstitial nephritis. Evidence for selective distal tubular dysfunction. Am J Med. 1978;64:500–7.PubMed Cogan MC, Arieff AI. Sodium wasting, acidosis and hyperkalemia induced by methicillin interstitial nephritis. Evidence for selective distal tubular dysfunction. Am J Med. 1978;64:500–7.PubMed
224.
go back to reference Johnson RJ, Feehally J. Comprehensive clinical nephrology. London: Mosby; 2000. Johnson RJ, Feehally J. Comprehensive clinical nephrology. London: Mosby; 2000.
225.
go back to reference Bogdanovic R, Stajic N, Putnik J, Paripovic A. Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review. Pediatr Nephrol. 2009;24:2167–75.PubMed Bogdanovic R, Stajic N, Putnik J, Paripovic A. Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review. Pediatr Nephrol. 2009;24:2167–75.PubMed
226.
go back to reference Moritz ML, Ayus JC. 100 cc 3 % sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010;25:91–6.PubMed Moritz ML, Ayus JC. 100 cc 3 % sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010;25:91–6.PubMed
227.
go back to reference Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20 % mannitol solution and a 7.5 % saline/6 % dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196–202 (discussion 198–257). Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20 % mannitol solution and a 7.5 % saline/6 % dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196–202 (discussion 198257).
228.
go back to reference Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991;19:758–62.PubMed Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991;19:758–62.PubMed
229.
go back to reference Sterns RH, Hix JK, Silver SM. Management of hyponatremia in the ICU. Chest. 2013;144:672–9.PubMed Sterns RH, Hix JK, Silver SM. Management of hyponatremia in the ICU. Chest. 2013;144:672–9.PubMed
230.
go back to reference Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120:S1–21.PubMed Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120:S1–21.PubMed
231.
go back to reference Berl T. The Adrogue-Madias formula revisited. Clin J Am Soc Nephrol. 2007;2:1098–9.PubMed Berl T. The Adrogue-Madias formula revisited. Clin J Am Soc Nephrol. 2007;2:1098–9.PubMed
232.
go back to reference Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med. 1987;317:1190–5.PubMed Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med. 1987;317:1190–5.PubMed
233.
go back to reference Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110–7.PubMed Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110–7.PubMed
234.
go back to reference Nguyen MK, Kurtz I. New insights into the pathophysiology of the dysnatremias: a quantitative analysis. Am J Physiol Renal Physiol. 2004;287:F172–80.PubMed Nguyen MK, Kurtz I. New insights into the pathophysiology of the dysnatremias: a quantitative analysis. Am J Physiol Renal Physiol. 2004;287:F172–80.PubMed
235.
go back to reference Ali SS, Olinger CC, Sobotka PA, Dahle TG, Bunte MC, Blake D, Boyle AJ. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15:1–4.PubMed Ali SS, Olinger CC, Sobotka PA, Dahle TG, Bunte MC, Blake D, Boyle AJ. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15:1–4.PubMed
236.
go back to reference Hew-Butler T, Almond C, Ayus JC, Dugas J, Meeuwisse W, Noakes T, Reid S, Siegel A, Speedy D, Stuempfle K, et al. Consensus statement of the 1st international exercise-associated hyponatremia consensus development conference, Cape Town, South Africa 2005. Clin J Sport Med. 2005;15:208–13.PubMed Hew-Butler T, Almond C, Ayus JC, Dugas J, Meeuwisse W, Noakes T, Reid S, Siegel A, Speedy D, Stuempfle K, et al. Consensus statement of the 1st international exercise-associated hyponatremia consensus development conference, Cape Town, South Africa 2005. Clin J Sport Med. 2005;15:208–13.PubMed
237.
go back to reference Hsieh M. Recommendations for treatment of hyponatraemia at endurance events. Sports Med. 2004;34:231–8.PubMed Hsieh M. Recommendations for treatment of hyponatraemia at endurance events. Sports Med. 2004;34:231–8.PubMed
238.
go back to reference Ayus JC, Arieff AI. Noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;133:1011.PubMed Ayus JC, Arieff AI. Noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;133:1011.PubMed
239.
go back to reference Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–4.PubMed Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–4.PubMed
240.
go back to reference Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881–93.PubMed Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881–93.PubMed
241.
go back to reference Overgaard-Steensen C. Initial approach to the hyponatremic patient. Acta Anaesthesiol Scand. 2011;55:139–48.PubMed Overgaard-Steensen C. Initial approach to the hyponatremic patient. Acta Anaesthesiol Scand. 2011;55:139–48.PubMed
242.
go back to reference Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int. 1994;45:193–200.PubMed Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int. 1994;45:193–200.PubMed
243.
go back to reference Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int. 2009;76:614–21. Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int. 2009;76:614–21.
244.
go back to reference Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57:1931–2.PubMed Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57:1931–2.PubMed
245.
go back to reference Yamada H, Takano K, Ayuzawa N, Seki G, Fujita T. Relowering of serum na for osmotic demyelinating syndrome. Case Rep Neurol Med. 2012;2012:704639.PubMedCentralPubMed Yamada H, Takano K, Ayuzawa N, Seki G, Fujita T. Relowering of serum na for osmotic demyelinating syndrome. Case Rep Neurol Med. 2012;2012:704639.PubMedCentralPubMed
246.
go back to reference Rafat C, Schortgen F, Gaudry S, Bertrand F, Miguel-Montanes R, Labbe V, Ricard JD, Hajage D, Dreyfuss D. Use of desmopressin acetate in severe hyponatremia in the intensive care unit. Clin J Am Soc Nephrol. 2013;9(2):229–37. Rafat C, Schortgen F, Gaudry S, Bertrand F, Miguel-Montanes R, Labbe V, Ricard JD, Hajage D, Dreyfuss D. Use of desmopressin acetate in severe hyponatremia in the intensive care unit. Clin J Am Soc Nephrol. 2013;9(2):229–37.
247.
go back to reference Perianayagam A, Sterns RH, Silver SM, Grieff M, Mayo R, Hix J, Kouides R. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–6.PubMedCentralPubMed Perianayagam A, Sterns RH, Silver SM, Grieff M, Mayo R, Hix J, Kouides R. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–6.PubMedCentralPubMed
248.
go back to reference Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013;61:571–8.PubMed Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013;61:571–8.PubMed
249.
go back to reference Sugimura Y, Murase T, Takefuji S, Hayasaka S, Takagishi Y, Oiso Y, Murata Y. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol. 2005;192:178–83.PubMed Sugimura Y, Murase T, Takefuji S, Hayasaka S, Takagishi Y, Oiso Y, Murata Y. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol. 2005;192:178–83.PubMed
250.
go back to reference Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol. 2006;65:37–44.PubMed Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol. 2006;65:37–44.PubMed
251.
go back to reference Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol. 2002;13:1255–60.PubMed Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol. 2002;13:1255–60.PubMed
252.
go back to reference Gross PA, Wagner A, Decaux G. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet. Kidney Int. 2011;80:594–600.PubMed Gross PA, Wagner A, Decaux G. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet. Kidney Int. 2011;80:594–600.PubMed
253.
go back to reference Coussement J, Danguy C, Zouaoui-Boudjeltia K, Defrance P, Bankir L, Biston P, Piagnerelli M. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. Am J Nephrol. 2012;35:265–70.PubMed Coussement J, Danguy C, Zouaoui-Boudjeltia K, Defrance P, Bankir L, Biston P, Piagnerelli M. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. Am J Nephrol. 2012;35:265–70.PubMed
254.
go back to reference Pierrakos C, Taccone FS, Decaux G, Vincent JL, Brimioulle S. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience. Ann Intensive Care. 2012;2:13.PubMedCentralPubMed Pierrakos C, Taccone FS, Decaux G, Vincent JL, Brimioulle S. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience. Ann Intensive Care. 2012;2:13.PubMedCentralPubMed
255.
go back to reference Forrest JN Jr, Cox M, Hong C, Morrison G, Bia M, Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med. 1978;298:173–7.PubMed Forrest JN Jr, Cox M, Hong C, Morrison G, Bia M, Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med. 1978;298:173–7.PubMed
256.
go back to reference De Troyer A, Demanet JC. Correction of antidiuresis by demeclocycline. N Engl J Med. 1975;293:915–8.PubMed De Troyer A, Demanet JC. Correction of antidiuresis by demeclocycline. N Engl J Med. 1975;293:915–8.PubMed
257.
go back to reference Braden GL, Geheb MA, Shook A, Singer I, Cox M. Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies. Am J Kidney Dis. 1985;5:270–7.PubMed Braden GL, Geheb MA, Shook A, Singer I, Cox M. Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies. Am J Kidney Dis. 1985;5:270–7.PubMed
258.
go back to reference Robertson GL. Vaptans for the treatment of hyponatremia. Nat Rev Endocrinol. 2011;7:151–61.PubMed Robertson GL. Vaptans for the treatment of hyponatremia. Nat Rev Endocrinol. 2011;7:151–61.PubMed
259.
go back to reference Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–112.PubMed Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–112.PubMed
260.
go back to reference Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332–43.PubMed Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332–43.PubMed
261.
go back to reference Gines P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008;48:204–13.PubMed Gines P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008;48:204–13.PubMed
262.
go back to reference Lehrich RW, Ortiz-Melo DI, Patel MB, Greenberg A. Role of vaptans in the management of hyponatremia. Am J Kidney Dis. 2013;62:364–76.PubMed Lehrich RW, Ortiz-Melo DI, Patel MB, Greenberg A. Role of vaptans in the management of hyponatremia. Am J Kidney Dis. 2013;62:364–76.PubMed
263.
go back to reference Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant. 2010;25:1524–31.PubMed Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant. 2010;25:1524–31.PubMed
264.
go back to reference Human T, Onuoha A, Diringer M, Dhar R. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury. J Crit Care. 2012;27(745):e741–5. Human T, Onuoha A, Diringer M, Dhar R. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury. J Crit Care. 2012;27(745):e741–5.
265.
go back to reference Jones RC, Rajasekaran S, Rayburn M, Tobias JD, Kelsey RM, Wetzel GT, Cabrera AG. Initial experience with conivaptan use in critically ill infants with cardiac disease. J Pediatr Pharmacol Ther. 2012;17:78–83.PubMedCentralPubMed Jones RC, Rajasekaran S, Rayburn M, Tobias JD, Kelsey RM, Wetzel GT, Cabrera AG. Initial experience with conivaptan use in critically ill infants with cardiac disease. J Pediatr Pharmacol Ther. 2012;17:78–83.PubMedCentralPubMed
266.
go back to reference Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol. 2007;27:447–57.PubMed Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol. 2007;27:447–57.PubMed
267.
go back to reference Friedman B, Cirulli J. Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan. J Crit Care. 2013;28(219):e211–2. Friedman B, Cirulli J. Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan. J Crit Care. 2013;28(219):e211–2.
Metadata
Title
Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?
Authors
Cédric Rafat
Martin Flamant
Stéphane Gaudry
Emmanuelle Vidal-Petiot
Jean-Damien Ricard
Didier Dreyfuss
Publication date
01-12-2015
Publisher
Springer Paris
Published in
Annals of Intensive Care / Issue 1/2015
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-015-0066-8

Other articles of this Issue 1/2015

Annals of Intensive Care 1/2015 Go to the issue